{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T05:15:30Z","timestamp":1763442930429,"version":"3.45.0"},"reference-count":23,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T00:00:00Z","timestamp":1763424000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:p>Lipodystrophy is a rare group of conditions characterized by partial or total absence of adipose tissue in the body. The lipodystrophy is either congenital or acquired and is also classified further to either generalized or partial. Lipodystrophy is associated with severe insulin resistance and metabolic disorders due to ectopic fat deposition. The therapeutic approach of lipodystrophy is limited to preventing the exacerbation of complications associated to metabolic disorders and include low fat diet and exercise in combination with medication for diabetes control and fibrates or statins to control dyslipidemia. Metreleptin is an adjunctive injectable treatment for people with generalized lipodystrophy due to leptin deficiency aiming to improve appetite and metabolic markers. Metreleptin treatment has also beneficial impact on liver and kidney function, the cardiovascular and the reproductive system and fertility. In the current paper we present a rare case of a female patient of reproductive age with congenital generalized lipodystrophy type 1 who received metreleptin treatment for the control of her diabetes and metabolic disorders. After 13 months of treatment with metreleptin the patient conceived spontaneously and delivered a healthy neonate. This rare and educational case indicates that metreleptin plays a key role in the adipose-mediated regulation of fertility.<\/jats:p>","DOI":"10.3389\/fendo.2025.1715799","type":"journal-article","created":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T05:13:14Z","timestamp":1763442794000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Case Report: Metreleptin treatment enables successful pregnancy in a female with congenital generalized lipodystrophy"],"prefix":"10.3389","volume":"16","author":[{"given":"Maria","family":"Somali","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emmanouil","family":"Korakas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eirini","family":"Pizirtzidou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zoe A.","family":"Efstathiadou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michail","family":"Sapranidis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zadalla","family":"Mouslech","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,11,18]]},"reference":[{"key":"B1","article-title":"Lipodystrophy syndromes: presentation and treatment","volume-title":"Endotext","author":"Akinci","year":"2024"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ecl.2017.01.012","article-title":"Genetics of lipodystrophy","volume":"46","author":"Lightbourne","year":"2017","journal-title":"Endocrinol Metab Clin North Am"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2016-2466","article-title":"The diagnosis and management of lipodystrophy syndromes: A multi-society practice guideline","volume":"101","author":"Brown","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2024.1383318","article-title":"A rapid action plan to improve diagnosis and management of lipodystrophy syndromes","volume":"15","author":"Fourman","year":"2024","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B5","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1586\/17512433.2016.1096772","article-title":"Metreleptin for injection to treat the complications of leptin deficiency in patients with congenital or acquired generalized lipodystrophy","volume":"9","author":"Meehan","year":"2016","journal-title":"Expert Rev Clin Pharmacol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1080\/03007995.2022.2059974","article-title":"Metreleptin for the treatment of lipodystrophy: leading the way among novel therapeutics for this unmet clinical need","volume":"38","author":"Polyzos","year":"2022","journal-title":"Curr Med Res Opin"},{"key":"B7","doi-asserted-by":"publisher","first-page":"5416","DOI":"10.3390\/ijms26115416","article-title":"The role of the AGPAT2 gene in adipose tissue biology and congenital generalized lipodystrophy pathophysiology","volume":"26","author":"de Melo","year":"2025","journal-title":"Int J Mol Sci"},{"key":"B8","doi-asserted-by":"publisher","first-page":"bqaa204","DOI":"10.1210\/endocr\/bqaa204","article-title":"The importance of leptin to reproduction","volume":"162","author":"Childs","year":"2021","journal-title":"Endocrinology"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1172\/JCI45106","article-title":"Leptin\u2019s effect on puberty in mice is relayed by the ventral premammillary nucleus and does not require signaling in Kiss1 neurons","volume":"121","author":"Donato","year":"2011","journal-title":"J Clin Invest"},{"key":"B10","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.ajog.2013.11.009","article-title":"Serum leptin levels and reproductive function during the menstrual cycle","volume":"210","author":"Ahrens","year":"2014","journal-title":"Am J Obstet Gynecol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1210\/en.2017-00586","article-title":"Association of Gnrhr mRNA with the stem cell determinant Musashi: a mechanism for leptin-mediated modulation of GnRHR expression","volume":"159","author":"Odle","year":"2018","journal-title":"Endocrinology"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1095\/biolreprod.102.010702","article-title":"Biphasic effects of leptin in porcine granulosa cells","volume":"68","author":"Ruiz-Cort\u00e9s","year":"2003","journal-title":"Biol Reprod"},{"key":"B13","article-title":"Berardinelli-seip congenital lipodystrophy","volume-title":"GeneReviews","author":"Van Maldergem","year":"2003"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa040388","article-title":"Recombinant human leptin in women with hypothalamic amenorrhea","volume":"351","author":"Welt","year":"2004","journal-title":"N Engl J Med"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2004.08.021","article-title":"The long-term effect of recombinant methionyl human leptin therapy on hyperandrogenism and menstrual function in female and pituitary function in male and female hypoleptinemic lipodystrophic patients","volume":"54","author":"Musso","year":"2005","journal-title":"Metabolism"},{"key":"B16","doi-asserted-by":"publisher","first-page":"2508188","DOI":"10.1080\/21623945.2025.2508188","article-title":"One-year metreleptin in Colombian sisters with congenital leptin deficiency","volume":"14","author":"Yupanqui-Lozno","year":"2025","journal-title":"Adipocyte"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.13369","article-title":"Leptin action in normal and pathological pregnancies","volume":"22","author":"P\u00e9rez-P\u00e9rez","year":"2018","journal-title":"J Cell Mol Med"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1006\/dbio.2000.9767","article-title":"Embryo implantation","volume":"223","author":"Carson","year":"2000","journal-title":"Dev Biol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.placenta.2015.01.006","article-title":"Leptin promotes HLA-G expression on placental trophoblasts via the MEK\/Erk and PI3K signaling pathways","volume":"36","author":"Barrientos","year":"2015","journal-title":"Placenta"},{"key":"B20","doi-asserted-by":"publisher","first-page":"bvad114","DOI":"10.1210\/jendso\/bvad114.736","article-title":"THU301 natural history of pregnancy and pregnancy outcomes in subjects with lipodystrophy","volume":"7","author":"Neal","year":"2023","journal-title":"J Endocr Soc"},{"key":"B21","doi-asserted-by":"publisher","first-page":"bvae181","DOI":"10.1210\/jendso\/bvae181","article-title":"Acquired partial lipodystrophy: clinical management in a pregnant patient","volume":"8","author":"Romanisio","year":"2024","journal-title":"J Endocr Soc"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0b013e31822cecf7","article-title":"Pregnancy in a woman with congenital generalized lipodystrophy: leptin\u2019s vital role in reproduction","volume":"119","author":"Maguire","year":"2012","journal-title":"Obstet Gynecol"},{"key":"B23","unstructured":"Myalepta, INN-metreleptin: EPAR \u2013 product information"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2025.1715799\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T05:13:15Z","timestamp":1763442795000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2025.1715799\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,18]]},"references-count":23,"alternative-id":["10.3389\/fendo.2025.1715799"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2025.1715799","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,18]]},"article-number":"1715799"}}